The big pharma firm that saw the future

3 June 2021 - Long ago Roche bet on personalised health care. Now its time has come. ...

Read more →

FDA takes steps to provide clarity on developing new drug products in the age of individualised medicine

4 January 2021 - Advances in scientific knowledge and drug development technology have provided an opportunity for new approaches to drug ...

Read more →

COVID-19 raises questions about the value of personalised medicine

8 May 2020 - A group of medical dissenters argues that tailoring treatment to the genetic profiles of individuals, a longstanding ...

Read more →

Inside drug makers' strategy to boost cancer medicines with 'Lazarus effect'

6 September 2019 - In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus ...

Read more →

FDA warns testing companies: don’t tell patients how their DNA influences response to specific drugs

28 August 2019 - Amid a boom in genetic testing that aims to predict a person’s response to medication, the ...

Read more →

Are we being misled about precision medicine?

12 September 2018 - Doctors and hospitals love to talk about the cancer patients they’ve saved, and reporters love to write ...

Read more →

Comparison of two treatment models: precision medicine and preventive medicine

28 August 2018 - In an effort to improve the risk-benefit profile of therapies in clinical care, precision medicine seeks to ...

Read more →

Precision medicine success hinges on diagnostics' clinical utility

23 July 2018 - The companion diagnostic plays a significant role in precision medicine.  ...

Read more →

Evolving landscape of US FDA drug approval in the era of precision oncology: finding the right balance between access and safety

15 May 2018 - Since 1992, the US FDA has implemented several programs for streamlined review and approval of agents that ...

Read more →

Precision medicines have faster approvals based on fewer and smaller trials than other medicines

7 May 2018 - Precision medicines can benefit patients by increasing the probability of a successful treatment response in selected patient ...

Read more →

Statement from FDA Commissioner on new FDA efforts to support more efficient development of targeted therapies

15 December 2017 - In recent years, the medical community has experienced a shift in the way health care is ...

Read more →

Two recent scientific advances underscore an encouraging future for precision medicine at FDA

11 July 2017 - FDA helps bring precision medicine – in the form of targeted therapies — to people living ...

Read more →

FDA’s Pazdur and Blumenthal: the march of checkpoint inhibitors will continue

21 February 2017 - More approvals of new immune-checkpoint inhibitors, targeted and personalised therapies, as well as the use of ...

Read more →

The challenges of generating evidence to support precision medicine

13 February 2017 - Major recent advances in science and technology now enable new kinds of measurements that can characterise an ...

Read more →

A precision medicine approach to clinical trials

14 November 2016 - Five or 6 years ago, only 5% to 10% of patients at David Hong's clinic arrived with ...

Read more →